「ag」の検索結果
41件：26～30件目を表示
-
お知らせ | 千寿製薬株式会社
BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for Beeli...
http://www.senju.co.jp/english/news/ -
产品开发方针 | 研究与开发 | 千寿制药株式会社
f world population. 2024. #4: 横井则彦，加藤弘明：干眼症诊疗范式的变化 眼表面的分层诊断和分层治疗.京府医大期刊，2013 122(8):549-57 #5: Nakagawa T, Tokuda Y, Nakano M, Komori Y, Hanada N, Tourtas T, et al. RNA-Seq-based transcriptome analy...
http://www.senju.co.jp/chinese/rd/policy/ -
Publications | Research & Development | SENJU Pharmaceutica
1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. P...
http://www.senju.co.jp/english/rd/thesis/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
te that the information may differ from the up-to-date information depending on when it is updated. Agree Disagree
http://www.senju.co.jp/english/rd/trial.html -
学会发表 | 研究与开发 | 千寿制药株式会社
5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Ats...
http://www.senju.co.jp/chinese/rd/society/